MGH IBS Study

MGH IBS Study Tenapanor is the newest FDA-approved agent for irritable bowel syndrome with constipation (IBS-C).

We are conducting a study to better understand how tenapanor affects the microbiome of patients with IBS-C through stool sample analysis.

Address

55 Fruit Street
Boston, MA
02114

Website

Alerts

Be the first to know and let us send you an email when MGH IBS Study posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category